121 related articles for article (PubMed ID: 8685096)
1. [P-glycoprotein expression in osteosarcoma].
Pösl M; Grahl K; Amling M; Werner M; Ritzel H; Stenzel I; Hentz M; Winkler K; Delling G
Pathologe; 1996 Jan; 17(1):50-5. PubMed ID: 8685096
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein expression in high grade central osteosarcoma and normal bone cells. An immunohistochemical study.
Pösl M; Amling M; Grahl K; Hentz M; Ritzel H; Werner M; Winkler K; Delling G
Gen Diagn Pathol; 1997 Jun; 142(5-6):317-25. PubMed ID: 9228255
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein expression: critical determinant in the response to osteosarcoma chemotherapy.
Chan HS; Grogan TM; Haddad G; DeBoer G; Ling V
J Natl Cancer Inst; 1997 Nov; 89(22):1706-15. PubMed ID: 9390540
[TBL] [Abstract][Full Text] [Related]
4. Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma.
Serra M; Maurici D; Scotlandi K; Barbanti-Brodano G; Manara MC; Benini S; Picci P; Bertoni F; Bacci G; Sottili S; Baldini N
Int J Oncol; 1999 Feb; 14(2):301-7. PubMed ID: 9917506
[TBL] [Abstract][Full Text] [Related]
5. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance and malignancy in human osteosarcoma.
Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
[TBL] [Abstract][Full Text] [Related]
7. Relationship between P-glycoprotein positivity, doxorubicin binding ability and histologic response to chemotherapy in osteosarcomas.
Kusuzaki K; Hirata M; Takeshita H; Murata H; Hashiguchi S; Ashihara T; Hirasawa Y
Cancer Lett; 1999 Apr; 138(1-2):203-8. PubMed ID: 10378794
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein levels predict poor outcome in patients with osteosarcoma.
Hornicek FJ; Gebhardt MC; Wolfe MW; Kharrazi FD; Takeshita H; Parekh SG; Zurakowski D; Mankin HJ
Clin Orthop Relat Res; 2000 Apr; (373):11-7. PubMed ID: 10810457
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of P-glycoprotein immunohistochemistry and doxorubicin binding assay in patients with osteosarcoma.
Kumta SM; Zhu QS; Lee KM; Griffith J; Chow LT; Leung PC
Int Orthop; 2001; 25(5):279-82. PubMed ID: 11794258
[TBL] [Abstract][Full Text] [Related]
10. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
[TBL] [Abstract][Full Text] [Related]
11. Effect of variation of ABCB1 and ABCC3 genotypes on the survival of bone tumor cases after chemotherapy.
Yang J; Wang ZG; Cai HQ; Li YC; Xu YL
Asian Pac J Cancer Prev; 2013; 14(8):4595-8. PubMed ID: 24083708
[TBL] [Abstract][Full Text] [Related]
12. [Therapy-induced changes in osteosarcoma after neoadjuvant chemotherapy (COSS 86 Therapy Study). Correlation between morphologic findings and clinical follow-up].
Werner M; Fuchs N; Salzer-Kuntschik M; Winkler K; Delling G
Pathologe; 1996 Jan; 17(1):35-43. PubMed ID: 8685094
[TBL] [Abstract][Full Text] [Related]
13. [Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].
Wei L; Song XR; Wang XW; Li M; Z uo WS
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):445-8. PubMed ID: 17152492
[TBL] [Abstract][Full Text] [Related]
14. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells.
Yamaguchi M; Kita K; Miwa H; Nishii K; Oka K; Ohno T; Shirakawa S; Fukumoto M
Cancer; 1995 Dec; 76(11):2351-6. PubMed ID: 8635042
[TBL] [Abstract][Full Text] [Related]
15. May P-glycoprotein status be used to stratify high-grade osteosarcoma patients? Results from the Italian/Scandinavian Sarcoma Group 1 treatment protocol.
Serra M; Pasello M; Manara MC; Scotlandi K; Ferrari S; Bertoni F; Mercuri M; Alvegard TA; Picci P; Bacci G; Smeland S
Int J Oncol; 2006 Dec; 29(6):1459-68. PubMed ID: 17088985
[TBL] [Abstract][Full Text] [Related]
16. Correlation of p-glycoprotein detection by immunohistochemistry with mdr-1 mRNA levels in osteosarcomas. Pilot study.
Kandel RA; Campbell S; Noble-Topham S; Bell R; Andrulis IL
Diagn Mol Pathol; 1995 Mar; 4(1):59-65. PubMed ID: 7735558
[TBL] [Abstract][Full Text] [Related]
17. Expression of the MDR1 gene product P-glycoprotein in childhood neuroblastoma.
Dhooge CR; De Moerloose BM; Benoit YC; Van Roy N; Philippé ; Laureys GG
Cancer; 1997 Oct; 80(7):1250-7. PubMed ID: 9317175
[TBL] [Abstract][Full Text] [Related]
18. Expression profiles of osteosarcoma that can predict response to chemotherapy.
Man TK; Chintagumpala M; Visvanathan J; Shen J; Perlaky L; Hicks J; Johnson M; Davino N; Murray J; Helman L; Meyer W; Triche T; Wong KK; Lau CC
Cancer Res; 2005 Sep; 65(18):8142-50. PubMed ID: 16166288
[TBL] [Abstract][Full Text] [Related]
19. Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype.
Radig K; Häckel C; Herting J; Oda Y; Mittler U; Neumann W; Roessner A
Gen Diagn Pathol; 1997 Feb; 142(3-4):139-45. PubMed ID: 9065577
[TBL] [Abstract][Full Text] [Related]
20. Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-glycoprotein expression in high-grade osteosarcoma.
Gorlick R; Liao AC; Antonescu C; Huvos AG; Healey JH; Sowers R; Daras M; Calleja E; Wexler LH; Panicek D; Meyers PA; Yeh SD; Larson SM
Clin Cancer Res; 2001 Oct; 7(10):3065-70. PubMed ID: 11595696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]